Engineers Gate Manager’s Niagen Bioscience NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-45,508
Closed -$201K 2712
2026
Q1
$201K Sell
45,508
-21,216
-32% -$115K ﹤0.01% 1905
2025
Q4
$424K Sell
66,724
-19,755
-23% -$137K 0.01% 1445
2025
Q3
$807K Buy
86,479
+51,404
+147% +$519K 0.01% 1266
2025
Q2
$505K Buy
+35,075
New +$346K 0.01% 1476
2025
Q1
Sell
-13,848
Closed -$73.5K 2667
2024
Q4
$73.5K Buy
+13,848
New +$75.8K ﹤0.01% 2035
2024
Q3
Sell
-11,025
Closed -$30.1K 2467
2024
Q2
$30.1K Buy
+11,025
New +$36.9K ﹤0.01% 1838
2022
Q3
Sell
-23,811
Closed -$40K 2151
2022
Q2
$40K Buy
+23,811
New +$46.6K ﹤0.01% 1801
2021
Q4
Sell
-17,122
Closed -$107K 2342
2021
Q3
$107K Sell
17,122
-15,461
-47% -$127K 0.01% 1525
2021
Q2
$321K Sell
32,583
-33,966
-51% -$296K 0.02% 1088
2021
Q1
$622K Buy
+66,549
New +$527K 0.03% 851
2019
Q4
Sell
-27,443
Closed -$108K 1882
2019
Q3
$108K Buy
+27,443
New +$117K 0.01% 1303

Other funds holding NAGE

Engineers Gate Manager's NAGE Position: Q2 2026 in Review

Engineers Gate Manager sold out of Niagen Bioscience (NAGE) in Q2 2026, closing a stake of 45,508 shares — an estimated $201K sold.

Engineers Gate Manager first reported a position in NAGE in Q3 2019 and held it in 11 quarters. The position peaked at $807K in Q3 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Engineers Gate Manager reported no remaining Niagen Bioscience position as of Q2 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 45,508 Niagen Bioscience shares in Q2 2026, an estimated $201K.
  • Engineers Gate Manager first reported a position in Niagen Bioscience in Q3 2019 and held it in 11 quarters.
  • Engineers Gate Manager's Niagen Bioscience position peaked at $807K in Q3 2025.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.